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Background
Natural variations in IL-15 concentration have not been
investigated for an association with an immune-protec-
tion against HIV. Given IL-15's central role in anti-HIV
immunity, we hypothesized that higher concentrations of
IL-15 in breast milk may protect against postnatal mother-
to-child HIV transmission.
Methods
In a case-control study nested within a clinical trial in
Zambia, we compared IL-15 concentrations in breast milk
of 22 HIV-infected women who transmitted HIV to their
infants through breastfeeding with those of 72 who did
not, as well as 18 HIV-uninfected women. Breast milk HIV
RNA quantity, sodium, CXCL12, CCL5, and IL-8 concen-
trations were measured as well as maternal plasma HIV
RNA concentrations and CD4 cell count. We used logistic
regression modeling to adjust for potential confounders.
Results
Higher concentrations of IL-15 in breast milk (adjusted
odds ratio [AOR]: 0.01 per log10 pg/ml increase, 95%
confidence interval [CI]: <0.001 to 0.3) were associated
with protection against postnatal HIV transmission in
univariate analysis and after adjusting for maternal CD4
cell counts, breast milk HIV RNA, CCL5, CXCL12, and IL-
8 concentrations. Breast milk IL-15 concentration corre-
lated with breast milk sodium, the other cytokines and
HIV RNA concentration. It was inversely correlated with
infant birth weight and tended to be higher in 1 week than
in 1 month post-partum samples. Breast milk CCL5 con-
centrations were associated with increased risk of HIV
transmission (AOR: 12.7 95% CI: 1.6 to 102.0) in
adjusted analysis. Breast milk CXCL12 and IL-8 concen-
trations were not independently associated with transmis-
sion.
Conclusion
High concentration of IL-15 were associated with a protec-
tion against breastfeeding HIV transmission after adjust-
ing for other pro-inflammatory cytokines, HIV RNA in
breast milk, and maternal CD4 cell count. These results
corroborate a protective role of IL-15-mediated cellular
immunity against HIV transmission during breastfeeding.
They are informative for vaccination studies using IL-15 as
an adjuvant.
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